Cargando…
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial
BACKGROUND: Magnesium sulphate is a neuroprotective agent that might improve outcome after aneurysmal subarachnoid haemorrhage by reducing the occurrence or improving the outcome of delayed cerebral ischaemia. We did a trial to test whether magnesium therapy improves outcome after aneurysmal subarac...
Autores principales: | Mees, Sanne M Dorhout, Algra, Ale, Vandertop, W Peter, van Kooten, Fop, Kuijsten, Hans AJM, Boiten, Jelis, van Oostenbrugge, Robert J, Salman, Rustam Al-Shahi, Lavados, Pablo M, Rinkel, Gabriel JE, van den Bergh, Walter M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391717/ https://www.ncbi.nlm.nih.gov/pubmed/22633825 http://dx.doi.org/10.1016/S0140-6736(12)60724-7 |
Ejemplares similares
-
Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT)
por: Dorhout Mees, Sanne M., et al.
Publicado: (2011) -
Effect of magnesium on cognition after aneurysmal subarachnoid haemorrhage in a randomized trial
por: Huenges Wajer, I. M. C., et al.
Publicado: (2018) -
Functional outcome and quality of life 5 and 12.5 years after aneurysmal subarachnoid haemorrhage
por: Greebe, Paut, et al.
Publicado: (2010) -
Nurses' prediction of volume status after aneurysmal subarachnoid haemorrhage: a prospective cohort study
por: Hoff, Reinier G, et al.
Publicado: (2008) -
Hypopituitarism after subarachnoid haemorrhage, do we know enough?
por: Khajeh, Ladbon, et al.
Publicado: (2014)